WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 13'5101 Infant (under 12 months) mortality rate: 92
GDP / capita (US$): 16'0371 Child (under 5 years) mortality rate: 102

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 3'395  3'383  3'372  3'360  3'349  3'321  3'110  2'916 
Births 49  50  50  50  50  54  57  56 
Surviving infants 49  49  49  49  50  53  56  54 
Pop. less than 5 years 245  246  247  248  249  271  271  277 
Pop. less than 15 years 749  754  759  765  771  815  809  785 
Female 15-49 years 819  817  815  813  811  806  743  696 

Number of reported case

(Click for retrospective incidence data for Uruguay)
Diphtheria
Japanese encephalitis
Measles 110  141 
Mumps 113  132  169  256  641  20 
Pertussis 598  639  36  128  161  192 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 15 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Uruguay)
Vaccine year result method % card seen                                                
BCG          99  99  99  99  99  99  99  56 
DTP1          98  99  98  98  98  92 
DTP3          95  95  95  95  94  90  97  53 
HepB_BD         
HepB3          95  95  95  95  94  92 
Hib3          95  95  95  95  94  88 
JapEnc         
MCV          96  95  95  95  95  89  97  50 
MCV2         
PCV1          97  99  99  70  70 
PCV3          93  92  91 
Pol3          95  95  95  95  94  92  97  59 
Rota1         
Rota_last         
Rubella1          96  95  95  95  95 
TT2plus          18 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Uruguay)
BCG 99  99  99  99  99  99  99  56 
DTP1 98  99  98  99  98  92  98  77 
DTP3 95  95  95  95  94  90  97  53 
HepB3 95  95  95  95  94  92 
Hib3 95  95  95  95  94  88 
MCV 96  95  95  94  95  89  97  50 
PCV3 93  92  91 
Pol3 95  95  95  95  94  92  97  59 
Rota_last

Number of districts in the country 275  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 2, 4, 6, 15 months; Yes contra-indication to pertussis
DTwP 5 years; Yes
DTwPHibHep 2, 4, 6, 15 months; Yes
HIB 2, 4, 6, 15 months; Yes contra- indication to pertussis
HepA 15, 21 months; Yes
HepB 2, 4, 6, 15 months; Yes Contra-indication to pertussis
IPV 2, 4, 6, 12 months; Yes
Influenza 6 months to 4 years; Yes risk groups, HCW and PW
MMR 1, 5 years; Yes
Pneumo_conj 2, 4 months; 1 year; Yes
Pneumo_ps > =65 years; Yes and risk groups
Td 22 years; Yes
Tdap 12 years; Yes
Varicella 1 year; Yes
YF Yes travelers

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2015  2010-2015  2010-2015  2009-2010  2008-2009  2003-2007   
Nº of districts with microplans that include activities to raise immunization coverage number     275    NA     

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 275  275  275  275  275  275  275 
Nº districts with DTP3 coverage >=80% number 275  275  275  275  275  275  275 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 264  253  250  256  256     
% of districts with MCV1 coverage >=95% From 0 to 100% 96  92  91  93  93     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR   Yes  Yes  Yes  Yes  Yes  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND   Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%   100  100    100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.